🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Miguel Quijada‐Álamo

Icahn School of Medicine at Mount Sinai

ORCID: 0000-0002-4831-4565

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia”.

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia

Leukemia(2022)10.1038/s41375-022-01543-y

N/A

0DataRank · unranked

31 citations

Laura Z. Rassenti, Michael Y. Choi, Miguel Quijada‐Álamo, Elvin Chu, George F. Widhopf +2 more

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia

Cancer Discovery(2025)10.1158/2159-8290.cd-25-0556

N/A

0DataRank · unranked

2 citations

Shayan Saniei, Nikita Poddar, Isabella G. Martinez, C. Chao, Subrina Persaud +45 more

Overcoming B-ALL Resistance to Targeted and Immune Therapies by Rational Combination Strategies

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0036

N/A

0DataRank · unranked

1 citations

Grace S. Freed, Elvin Wagenblast, Miguel Quijada‐Álamo